CA3037614A1 - Methods for diagnosing and treating a heart condition in a patient - Google Patents

Methods for diagnosing and treating a heart condition in a patient

Info

Publication number
CA3037614A1
CA3037614A1 CA3037614A CA3037614A CA3037614A1 CA 3037614 A1 CA3037614 A1 CA 3037614A1 CA 3037614 A CA3037614 A CA 3037614A CA 3037614 A CA3037614 A CA 3037614A CA 3037614 A1 CA3037614 A1 CA 3037614A1
Authority
CA
Canada
Prior art keywords
gas
patient
cartridge
air
lungs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA3037614A
Other languages
English (en)
French (fr)
Inventor
David H. Fine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vero Biotech Inc
Original Assignee
Vero Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vero Biotech Inc filed Critical Vero Biotech Inc
Publication of CA3037614A1 publication Critical patent/CA3037614A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA3037614A 2008-07-24 2009-07-24 Methods for diagnosing and treating a heart condition in a patient Abandoned CA3037614A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8338608P 2008-07-24 2008-07-24
US61/083,386 2008-07-24
CA2730011A CA2730011C (en) 2008-07-24 2009-07-24 Methods for diagnosing and treating a heart condition in a patient

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA2730011A Division CA2730011C (en) 2008-07-24 2009-07-24 Methods for diagnosing and treating a heart condition in a patient

Publications (1)

Publication Number Publication Date
CA3037614A1 true CA3037614A1 (en) 2010-01-28

Family

ID=41570625

Family Applications (2)

Application Number Title Priority Date Filing Date
CA3037614A Abandoned CA3037614A1 (en) 2008-07-24 2009-07-24 Methods for diagnosing and treating a heart condition in a patient
CA2730011A Expired - Fee Related CA2730011C (en) 2008-07-24 2009-07-24 Methods for diagnosing and treating a heart condition in a patient

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA2730011A Expired - Fee Related CA2730011C (en) 2008-07-24 2009-07-24 Methods for diagnosing and treating a heart condition in a patient

Country Status (6)

Country Link
US (1) US11000484B2 (OSRAM)
EP (2) EP2306814B1 (OSRAM)
JP (2) JP6058888B2 (OSRAM)
AU (1) AU2009273911B2 (OSRAM)
CA (2) CA3037614A1 (OSRAM)
WO (1) WO2010011928A1 (OSRAM)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090241956A1 (en) * 2008-03-27 2009-10-01 Nellcor Puritan Bennett Llc Method for controlling delivery of breathing gas to a patient using multiple ventilation parameters
US8640699B2 (en) 2008-03-27 2014-02-04 Covidien Lp Breathing assistance systems with lung recruitment maneuvers
JP6058888B2 (ja) 2008-07-24 2017-01-11 ゲノ エルエルシー 患者における心臓の病気の診断及び治療方法
CN105214193B (zh) * 2009-05-27 2017-11-17 马林克罗特医疗产品知识产权公司 用于药物递送调节装置的分度药物收容装置组件及分度药物递送系统
ES2873089T3 (es) * 2010-02-01 2021-11-03 Vero Biotech LLC Sistema de administración de óxido nítrico
AU2011245476B2 (en) 2010-04-26 2016-05-12 VERO Biotech LLC. Delivery of ultra pure nitric oxide (NO)
US8638200B2 (en) 2010-05-07 2014-01-28 Covidien Lp Ventilator-initiated prompt regarding Auto-PEEP detection during volume ventilation of non-triggering patient
US8607788B2 (en) 2010-06-30 2013-12-17 Covidien Lp Ventilator-initiated prompt regarding auto-PEEP detection during volume ventilation of triggering patient exhibiting obstructive component
US8607790B2 (en) 2010-06-30 2013-12-17 Covidien Lp Ventilator-initiated prompt regarding auto-PEEP detection during pressure ventilation of patient exhibiting obstructive component
US8607791B2 (en) 2010-06-30 2013-12-17 Covidien Lp Ventilator-initiated prompt regarding auto-PEEP detection during pressure ventilation
US8607789B2 (en) 2010-06-30 2013-12-17 Covidien Lp Ventilator-initiated prompt regarding auto-PEEP detection during volume ventilation of non-triggering patient exhibiting obstructive component
US8595639B2 (en) 2010-11-29 2013-11-26 Covidien Lp Ventilator-initiated prompt regarding detection of fluctuations in resistance
US8757153B2 (en) 2010-11-29 2014-06-24 Covidien Lp Ventilator-initiated prompt regarding detection of double triggering during ventilation
US8757152B2 (en) 2010-11-29 2014-06-24 Covidien Lp Ventilator-initiated prompt regarding detection of double triggering during a volume-control breath type
WO2012075420A1 (en) 2010-12-03 2012-06-07 Geno Llc Nitric oxide treatments
US9038633B2 (en) 2011-03-02 2015-05-26 Covidien Lp Ventilator-initiated prompt regarding high delivered tidal volume
CA2837341C (en) 2011-05-27 2021-10-19 Geno Llc Method of determining vasoreactivity using inhaled nitric oxide
JP2014523533A (ja) * 2011-07-07 2014-09-11 スクリップス ヘルス 心血管障害を分析する方法及びその用途
US20130145731A1 (en) * 2011-12-07 2013-06-13 Ecolab Usa Inc. Apparatus and method for configuring and opening product packaging
MX368858B (es) * 2012-03-15 2019-10-18 Mallinckrodt Hospital Products Ip Ltd Metodos para administrar altas concentraciones de oxido nitrico.
US9027552B2 (en) 2012-07-31 2015-05-12 Covidien Lp Ventilator-initiated prompt or setting regarding detection of asynchrony during ventilation
TWI590837B (zh) * 2014-03-25 2017-07-11 林信湧 一種用於治療心臟病之吸入式醫藥組成物及其備製方法
CN110770163B (zh) 2017-02-27 2021-08-31 第三极股份有限公司 用于移动生成一氧化氮的系统和方法
CA3054656A1 (en) 2017-02-27 2018-08-30 Third Pole, Inc. Systems and methods for generating nitric oxide
MX2020010523A (es) 2017-02-27 2021-02-09 Third Pole Inc Sistemas y metodos para generar oxido nitrico.
US11754538B1 (en) * 2018-07-18 2023-09-12 Vero Biotech Inc. Method and apparatus for automatic calibration
US11672938B1 (en) 2018-07-18 2023-06-13 Vero Biotech LLC Start-up protocols for nitric oxide delivery device
EP3969016A4 (en) 2019-05-15 2023-08-16 Third Pole, Inc. ARCHITECTURES FOR THE PRODUCTION OF NITROUS OXIDE
JP2022532654A (ja) 2019-05-15 2022-07-15 サード ポール，インコーポレイテッド 一酸化窒素を生成するシステム及び方法
JP2022533628A (ja) 2019-05-15 2022-07-25 サード ポール，インコーポレイテッド 一酸化窒素生成用電極
EP4069069A4 (en) 2020-01-11 2024-07-03 Third Pole, Inc. SYSTEMS AND METHODS FOR NITROGEN OXIDE PRODUCTION WITH HUMIDITY CONTROL
US20210395905A1 (en) 2020-06-18 2021-12-23 Third Pole, Inc. Systems and methods for preventing and treating infections with nitric oxide
US12509349B2 (en) 2020-10-16 2025-12-30 Third Pole, Inc. Nitric oxide generation process controls
EP4405019A4 (en) 2021-09-23 2025-07-16 Third Pole Inc SYSTEMS AND METHODS FOR PROVIDING NITRIC OXIDE
WO2023201363A2 (en) 2022-04-14 2023-10-19 Third Pole, Inc. Delivery of medicinal gas in a liquid medium

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5427797A (en) * 1993-04-06 1995-06-27 Brigham And Women's Hospital Systemic effects of nitric oxide inhalation
GB2279014B (en) * 1993-06-02 1997-07-16 Niall Keaney Device for controlling delivery of respiratory drugs
GB9320978D0 (en) * 1993-10-12 1993-12-01 Higenbottam Timohy W Nitric oxide treatment
US6063407A (en) * 1995-02-16 2000-05-16 The General Hospital Corporation Treatment of vascular thrombosis and restenosis with inhaled nitric oxide
US6165435A (en) * 1998-12-24 2000-12-26 Praxair Technology, Inc. Method and production of nitric acid
US6314956B1 (en) * 1999-09-08 2001-11-13 Duke University Pulmonary delivery of NO group-containing compound in gas form to treat respiratory, cardiac and blood disorders
WO2006023616A2 (en) * 2004-08-18 2006-03-02 Geno Llc Conversion of nitrogen dioxide (no2) to nitric oxide (no)
CA2550417A1 (en) * 2005-12-22 2007-06-22 Institut De Cardiologie De Montreal Method for maintaining cerebral hemispheric oxygen saturation during surgery
JP6058888B2 (ja) 2008-07-24 2017-01-11 ゲノ エルエルシー 患者における心臓の病気の診断及び治療方法

Also Published As

Publication number Publication date
WO2010011928A1 (en) 2010-01-28
EP2306814B1 (en) 2013-11-27
CA2730011C (en) 2019-05-07
EP2687086A1 (en) 2014-01-22
EP2687086B1 (en) 2016-09-14
JP2015145376A (ja) 2015-08-13
AU2009273911A1 (en) 2010-01-28
AU2009273911B2 (en) 2016-09-08
US11000484B2 (en) 2021-05-11
CA2730011A1 (en) 2010-01-28
JP2011529083A (ja) 2011-12-01
US20100030091A1 (en) 2010-02-04
EP2306814A4 (en) 2011-08-31
EP2306814A1 (en) 2011-04-13
JP6058888B2 (ja) 2017-01-11

Similar Documents

Publication Publication Date Title
CA2730011C (en) Methods for diagnosing and treating a heart condition in a patient
US12059661B2 (en) Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
AU2008232413B2 (en) Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
US8246725B2 (en) Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
JP5567617B2 (ja) 二酸化窒素（ｎｏ２）の酸化窒素（ｎｏ）への変換
Hammond et al. Hypertensive crisis managed by computer controlled infusion of sodium nitroprusside: a model for the closed loop administration of short acting vasoactive agents
AU2013267074B2 (en) Conversion of Nitrogen Dioxide (NO2) to Nitric Oxide (NO)

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20190320

FZDE Discontinued

Effective date: 20220621